Clinical Trial Update: B3 for NMD: Bench to Bedside and Back

View source ↗

Summary

The Ottawa Hospital Research Institute is enrolling participants in a neuromuscular disease study investigating B3 (trial NCT04417023).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuromuscular Disease

Drugs mentioned

• B3

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Neuromuscular Disease | Status: ENROLLING_BY_INVITATION